Previous reports identified BRAF mutations in 1–4% of cases of lung adenocarcinoma (12–15), and 40–50% of lung cancer cases have been demonstrated to harbor non-V600E mutations distributed in exons 11 and 15 (12–17). Here, BRAF is linked to lung adenocarcinoma.